News & IP updates

Urgent update – UKIPO suspends deadlines In light of the current coronavirus pandemic, the UKIPO has declared a “general interruption”. See here. It applies to all deadlines relating to UK patents, supplementary protection certificates, trade marks, registered designs, and applications for these rights as well as contentions proceedings including statutory deadlines and those set by staff members of the IPO under their discretionary powers.
March 2020
Beck Greener Podcast: Looking Closer - Employee-Inventor Wins £2 million Compensation! Beck Greener’s first podcast, concerning employee-inventor compensation in light of the recent UK Supreme Court landmark decision, Unilever v Shanks [2019] UKSC 45.
March 2020
Complaint against UPC Agreement and Implementing Act Upheld in Germany The German Constitutional court has today delivered its answer to the question as to whether the new European Unified...
March 2020
Important EUIPO Announcement The EUIPO announced this morning (16th March) that in view of the Covid-19 crisis, all time limits currently expiring...
March 2020
Announcement Coronavirus - Covid -19 We have all been following the news in relation to the rise of COVID-19. Our clients, whether in the UK, Europe or...
March 2020
A Can of Worms – Distinctiveness of sound marks before the General Court of the EU A trade mark is something which can be perceived by consumers as indicating the trade source of the goods or services...
March 2020
Beck Greener Ranked as Silver Tier Firm in WTR 1000 We are delighted to announce that Beck Greener has been recognised as a Silver Tier firm in the 2020 edition of the...
February 2020
Beck Greener Wins CITMA Charity Quiz Congratulations to Beck Greener’s quiz team for winning the CITMA 2020 quiz on 11 February 2020. Beck Greener's team...
February 2020
Brexit and IP - some frequently asked questions We have developed a series of FAQs to summarise the situation for IP protection in the UK and Europe after Brexit.
February 2020
EPO revokes Broad Institute’s CRISPR Patent The EPO’s Board of Appeal has upheld the revocation of one of the Broad Institute’s key patents for CRISPR/Cas9 gene...
February 2020

Pages